Town Crier

TEWKSBURY — In a press release issued last week by Attorney General Maura Healey’s office, it was announced that her office has sued a national addiction treatment center chain for submitting millions of dollars in false claims to the state’s Me­dicaid program, known as MassHealth, for urine drug tests that were medically unnecessary and violated federal and state self-referral laws because they were performed at the company’s own laboratory.

One of the locations of the program is in Tewks­bury. The attorney general’s office filed the action in U.S. District Court in Mas­sa­chusetts under the Mas­sachusetts False Claims Act against Total Wellness Centers, LLC, CleanSlate Centers, Inc., and CleanSlate Centers, LLC and former company owner Dr. Amanda Louise Wilson.

“This company’s business model was to illegally profit by cheating our state Medicaid program, which provides vital health care resources to some of our most vulnerable residents,” said AG Healey in a statement re­leased from her office. “We will take legal action against this kind of misconduct in order to recover funds for our state and protect the integrity of MassHealth.”

In March 2019, representatives of the Tewksbury office of Clean Slate gave an informational presentation to the Tewksbury Board of Health. Dr. Da­vid Tortorella and Krissy Naughton, NP, of The Clean Slate Center at 170 Main St. appeared before the board. Tortorella and Naughton explained that the center provides addiction medicine services. The Tewksbury location, which opened in 2014, is one of several centers in Massachusetts.

As of the March 2019 pre­sentation, Tortorella and Naughton said they ser­ved 350 patients from Tewksbury and surrounding communities, supporting people going through detox on a walk-in or call ahead basis, and those suffering with opioid and alcohol addiction.

The company was founded in Northampton, but has since moved its headquarters to Brentwood, Tennessee. The lawsuit, according to the press release, alleges that CleanSlate required pa­tients, depending on their stage of treatment, to submit to a variety of qualitative and quantitative ur­ine drug tests, some of which were medically un­necessary.

The AG’s Office also al­leges that CleanSlate and Dr. Wilson caused false claims to be submitted to MassHealth and its contracted managed care entities for these unneeded tests, which violate medical necessity requirements under MassHealth regulations.

During the presentation in 2019, CleanSlate’s Naugh­ton and Tortorella explained to the Board of Health that the program offers on-site counseling and case management, along with other supports. The center does not provide psychiatric services but does refer out. The cen­ter, at the time, work­ed closely with Tewks­bury’s substance use coordinator Maria Ruggiero and reported several positive outcomes.

When asked about the allegation, Tewksbury’s Health Director Susan Sawyer said, via email, she was not aware of this action and that the company had interacted with the town in prior years during a Hepatitis outbreak amongst addicts in Massachusetts.

Tewksbury Board of Health member Maria Za­roulis, who is also on the board of Tewksbury CARES, said via email, “This is the first I'm hearing about any of this. I've had nothing but good in­teractions with them, and they've been very helpful in supporting Tewksbury CARES.”

CleanSlate’s appearance before the Tewksbury Board of Health in 2019 was informational and not a result of any inquiry or action on the part of the town.

The press release goes on to say that “the AG’s complaint also alleges that the company’s policies, which directed clinicians at CleanSlate to refer laboratory work to its own Holyoke laboratory, violate federal and state self-referral sta­tutes. Dr. Wilson owned both the clinic and lab in Massachusetts and de­veloped the policies di­recting the self-referrals.”

The self-referral law prohibits referrals be­tween clinical laboratories and any entity with a direct or indirect ownership interest in the laboratory and vice versa. State law also prohibits a laboratory from testing any specimen received from an entity with an ownership interest in the laboratory. 

According to a spokes­person for the AG’s of­fice, via the press re­lease, “These allegations were originally made in a case filed in April 2017 under the whistleblower (or qui tam) provision of the False Claims Act. The act permits private parties to sue for fraud on behalf of the government, and it also permits federal and state governments to intervene in such actions, as Massa­chusetts has done in this case, which is captioned U.S. et al. ex rel. Wendy Welch v. CleanSlate Cen­ters, Inc., et al.; Civil Ac­tion No. 17-CV-30038-MGM (D. Mass.).”

According to the state, this matter is being handled by Managing At­torney Kevin Lownds, Assistant Attorney Gen­eral Gregoire Ucuz, Sen­ior Healthcare Fraud In­vestigator Steven Pfister, and Investigator William Welsh, all of the AG’s Medicaid Fraud Divi­sion, with substantial assistance from the U.S. Department of Health and Human Services, Of­fice of the Inspector General.

The AG’s Medicaid Fraud Division receives 75 percent of its funding from the U.S. Depart­ment of Health and Hu­man Services under a grant award. The re­main­ing 25 percent is funded by the Common­wealth of Massachusetts the notice from Healy’s office stated.

Clean Slate was contacted for comment for this story, but as of printing did not respond.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.